Enhancement of anti-tumor effect of antibody-drug conjugate in combination with nobiletin and other PMFs

被引:0
|
作者
Masuoka, Tomoya [1 ]
Iwasawa, Takumi [1 ]
Yonezawa, Takayuki [2 ]
Watanabe, Akio [3 ]
Woo, Jetae [2 ]
Kato, Kazunori [1 ]
机构
[1] Toyo Univ, Grad Sch Sci Eng, Tokyo, Japan
[2] Chubu Univ, Grad Sch Biotech, Kasugai, Aichi, Japan
[3] Jumonji Univ, Niiza, Saitama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
J-1046
引用
收藏
页码:393 / 393
页数:1
相关论文
共 50 条
  • [41] Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
    Wei, Qing
    Yang, Teng
    Zhu, Jiayu
    Zhang, Ziwen
    Yang, Le
    Zhang, Yuchao
    Hu, Can
    Chen, Jiahui
    Wang, Jinchao
    Tian, Xuefei
    Shimura, Takaya
    Fang, Jianmin
    Ying, Jieer
    Fan, Mengyang
    Guo, Peng
    Cheng, Xiangdong
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 984 - 997
  • [42] Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release
    Szot, Christopher
    Saha, Saurabh
    Zhang, Xiaoyan M.
    Zhu, Zhongyu
    Hilton, Mary Beth
    Morris, Karen
    Seaman, Steven
    Dunleavey, James M.
    Hsu, Kuo-Sheng
    Yu, Guo-Jun
    Morris, Holly
    Swing, Deborah A.
    Haines, Diana C.
    Wang, Yanping
    Hwang, Jennifer
    Feng, Yang
    Welsch, Dean
    DeCrescenzo, Gary
    Chaudhary, Amit
    Zudaire, Enrique
    Dimitrov, Dimiter S.
    St Croix, Brad
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2927 - 2943
  • [43] The preclinical pharmacology of PRO1102, a novel exatecan-based HER2-directed antibody-drug conjugate with robust anti-tumor activity
    Wang, Lei
    Liu, Haidong
    Shang, Xiao
    Han, Tae H.
    Zhao, Baiteng
    CANCER RESEARCH, 2022, 82 (12)
  • [44] PRO1184, a novel folate receptor alpha-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mouse carcinoma models
    Zhao, Baiteng
    Wang, Lei
    Liu, Haidong
    Huang, Suping
    Shang, Xiao
    Han, Tae
    CANCER RESEARCH, 2022, 82 (12)
  • [45] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Yang, Chang-yong
    Wang, Lei
    Sun, Xing
    Tang, Mi
    Quan, Hai-tian
    Zhang, Lian-shan
    Lou, Li-guang
    Gou, Shao-hua
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (07) : 971 - 979
  • [46] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Chang-yong Yang
    Lei Wang
    Xing Sun
    Mi Tang
    Hai-tian Quan
    Lian-shan Zhang
    Li-guang Lou
    Shao-hua Gou
    Acta Pharmacologica Sinica, 2019, 40 : 971 - 979
  • [47] Novel antibody-drug conjugates targeting Axl show anti-tumor activity in solid cancer xenograft models
    Breij, Esther C. W.
    Verploegen, Sandra
    Lingnau, Andreas
    van den Brink, Edward N.
    Janmaat, Maarten
    Houtkamp, Mischa
    Bleeker, Wim K.
    Satijn, David
    Parren, Paul W. H. I.
    CANCER RESEARCH, 2015, 75
  • [48] STUDIES ON ENHANCEMENT OF ANTI-TUMOR EFFECT .1. COMBINATION ANTI-TUMOR EFFECT WITH CENTRAL NERVOUS-SYSTEM DEPRESSANTS ON RAT ASCITES HEPATOMAS
    KOSHIURA, R
    MIYAMOTO, K
    SANAE, F
    GANN, 1980, 71 (01): : 45 - 51
  • [49] Glembatumumab vedotin (GV), an anti-gpNMB antibody-drug conjugate (ADC), in combination with varlilumab (V), an anti-CD27 antibody, in advanced melanoma
    Hamid, Omid
    Pavlick, Anna C.
    Cowey, C. Lance
    Hart, Lowell
    Johnson, Douglas B.
    Lutzky, Jose
    Alizadeh, Aaron
    Spigel, David
    Rothschild, Neal
    Salama, April
    Weber, Robert
    Luke, Jason J.
    Wang, Ying
    Yellin, Michael
    He, Yi
    Bagley, Rebecca G.
    Ott, Patrick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [50] A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
    D'Amico, Lucia
    Menzel, Ulrike
    Prummer, Michael
    Muller, Philipp
    Buchi, Melanie
    Kashyap, Abhishek
    Haessler, Ulrike
    Yermanos, Alexander
    Gebleux, Remy
    Briendl, Manfred
    Hell, Tamara
    Wolter, Fabian I.
    Beerli, Roger R.
    Truxova, Iva
    Radek, Spisek
    Vlajnic, Tatjana
    Grawunder, Ulf
    Reddy, Sai
    Zippelius, Alfred
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7